• Publications
  • Influence
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
TLDR
The 2016 Assessment of SpondyloArthritis international Society-EULAR recommendations provide up-to-date guidance on the management of patients with axSpA and three overarching principles and 13 recommendations deal with surgery and spinal fractures.
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
TLDR
It is found that glucocorticoid exposure of ≥10 mg/day is associated with a higher odds of hospitalisation and anti-TNF with a decreased odds ofospitalisation in patients with rheumatic disease.
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
TLDR
Cut-off values for disease activity states and improvement using the Ankylosing SpondyloArthritis Disease Activity Score have been developed and proved to have external validity and a good performance compared to existing criteria.
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
TLDR
There was broad agreement, now better supported by data than in 2012, that remission/inactive disease and, alternatively, low/minimal disease activity are the principal targets for the treatment of PsA.
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis
TLDR
Spinal mobility impairment in AS is independently determined both by irreversible spinal damage and by reversible spinal inflammation, as assessed by MRI in patients with ankylosing spondylitis.
Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR
TLDR
In early axial SpA patients, smoking was independently associated with earlier onset of IBP, higher disease activity, increase axial inflammation on MRI, increased axial structural damage on MRI and radiographs, poorer functional status and poorer quality of life.
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
TLDR
Among people with rheumatic disease, COVID-19-related death was associated with known general factors and disease-specific factors and the association with moderate/high disease activity highlights the importance of adequate disease control with DMARDs, preferably without increasing glucocorticoid dosages.
...
...